CARDLYTICS, INC. (CDLX) Free cash flow 2016–2025
CARDLYTICS, INC. (CDLX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$8.8MFY2025 · since FY2016: -$34.3M → $8.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.8M | +184.8% |
| FY2024 | -$10.4M | -1119.0% |
| FY2023 | -$852,000 | +98.5% |
| FY2022 | -$55.1M | -32.3% |
| FY2021 | -$41.6M | -220.1% |
| FY2020 | -$13.0M | -509.0% |
| FY2019 | $3.2M | +112.8% |
| FY2018 | -$24.9M | -6.9% |
| FY2017 | -$23.3M | +32.1% |
| FY2016 | -$34.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice